No connection

Search Results

Corporate Score 32 Neutral

IDT Executive Sells $1.02 Million in Shares Amid Strong Segment Growth

Apr 21, 2026 15:32 UTC
IDT
Medium term

Menachem Ash, EVP of Strategic & Legal Affairs at IDT Corporation, reduced his equity stake in a recent open-market transaction. The sale occurs against a backdrop of robust revenue growth and expanding margins for the telecommunications provider.

  • Insider sale of 20,000 shares at $51.00 per share
  • Quarterly revenue increased 6% to $320.5 million
  • Net2phone revenue surged 96% year-over-year
  • Fintech income grew by 32%
  • Gross profit margins expanded to 37.8%

Menachem Ash, Executive Vice President of Strategic & Legal Affairs at IDT Corporation (NYSE: IDT), sold 20,000 shares of common stock on April 14, 2026. The transaction, disclosed via an SEC Form 4 filing, was valued at approximately $1.02 million based on a reported price of $51.00 per share. Following the sale, Ash maintains a significant position in the company, holding 32,243 shares directly and an additional 2,875 shares through a 401(k) plan. Market analysts suggest the divestment is likely linked to compensation-related vesting and mechanical selling rather than a lack of confidence in the firm's trajectory, particularly as the stock has climbed roughly 10% year-to-date. IDT continues to demonstrate operational strength across its diversified telecommunications and payment solutions portfolio. The company recently posted quarterly revenue of $320.5 million, representing a 6% year-over-year increase. Gross profit rose 8% to $121.3 million, with margins expanding to 37.8%. Growth was driven primarily by the company's high-growth segments. Fintech income surged by 32%, while the net2phone division saw a dramatic 96% increase, highlighting strong digital engagement and effective operating leverage. While insider selling can occasionally signal internal caution, the scale of this transaction relative to the executive's total holdings and the company's underlying financial health suggests minimal impact on the stock's long-term outlook.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Share this article

Related Articles

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Home
Terminal
AI
Markets
Profile